| Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients TS Rodrigues, KSG de Sá, AY Ishimoto, A Becerra, S Oliveira, L Almeida, ... Journal of Experimental Medicine 218 (3), 2021 | 776 | 2021 |
| Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells ACG Salina, D Dos-Santos, TS Rodrigues, M Fortes-Rocha, ... Elife 11, e74443, 2022 | 37 | 2022 |
| Inflammasome activation in COVID-19 patients TS Rodrigues, KSG de Sá, AY Ishimoto, A Becerra, S Oliveira, L Almeida, ... MedRxiv, 2020.08. 05.20168872, 2020 | 36 | 2020 |
| Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection L de Almeida, ALN da Silva, TS Rodrigues, S Oliveira, AY Ishimoto, ... Science Advances 8 (37), eabo5400, 2022 | 19 | 2022 |
| Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory programming and continual clearance of apoptotic cells D dos-Santos, ACG Salina, TS Rodrigues, MF Rocha, EG Freitas-Filho, ... MedRxiv, 2021 | 15 | 2021 |
| Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection KSG de Sá, LA Amaral, TS Rodrigues, AY Ishimoto, WAC de Andrade, ... Nature Communications 14 (1), 1049, 2023 | 12 | 2023 |
| Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory programming and continual clearance of apoptotic cells ACG Salina, D dos-Santos, TS Rodrigues, M Fortes-Rocha, ... | | 2021 |
